secwatch.observer — SEC 8-K summary
======================================

Issuer:     Edgewise Therapeutics, Inc. (EWTX)
CIK:        0001710072
Form:       8-K
Filed at:   2022-06-24T23:59:59+00:00
Accession:  0001104659-22-074310
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Edgewise Therapeutics announces 2022 Annual Meeting voting results; two directors elected, KPMG ratified
--------------------------------------------------------------------------------

- Kenneth Harrison, Ph.D. elected with 37,108,884 votes for and 6,977,766 withheld (1,496,573 broker non-votes).
- Alan Russell, Ph.D. elected with 36,943,573 votes for and 7,143,077 withheld (1,496,573 broker non-votes).
- Ratification of KPMG LLP as independent auditor passed with 45,582,421 votes for, 614 against, 188 abstentions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1710072/000110465922074310/0001104659-22-074310-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1710072/000110465922074310/tm2219361d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-074310

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer